Great article @Flectional which describes a well trodden path of big Pharma acquiring promising drugs. IHL-42X comes to mind in this equation, as does the Psi-GAD program. And any acquisition would be multiple billions.
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil